Accenture CEO To Step Down After 8 Years In The Role For Health Reasons

Accenture PLC ACN, >+0.89% said Friday Chairman and Chief Executive Pierre Nanterme has stepped down, after 8 years as CEO, for health reasons. the company has named Chief Financial Officer David Rowland as interim CEO; KC McClure, who currently leads finance operations, as CFO; and Lead Independent Director Marge Magner as its non-executive chair. In July 2016, the company disclosed that Nanterme was diagnosed with colon cancer. The business consultant said there was no change to its outlook for the fiscal second quarter or fiscal 2019. The stock was little changed in premarket trade. It has lost 7.6% over the past 12 months while the S&P 500 SPX, >+1.32% has declined 6.2%.

Have breaking news sent to your inbox. Subscribe to MarketWatch's free Bulletin emails. Sign up here.

Source :

Accenture CEO to step down after 8 years in the role for health reasons
Accenture CEO Pierre Nanterme steps down due to health reasons
Stocks End Day in the Green as Dow, S&P Overcome Slow Starts
NCR Chairman and CEO Bill Nuti to Step Down for Health Reasons
Accenture Names William D. Green as Chief Executive Officer
Minimum Viable Advice: Working With Corporate Investors
Faurecia's (FURCF) CEO Patrick Koller on Full Year 2017 Results - Earnings Call Transcript
Canada to Test Advancements in Biometrics and Blockchain to Welcome International Travellers
Accenture CEO Pierre Nanterme Stepping Down for Health Reasons
Coca-Cola CEO Quincey to take on chairman role in April